FDA approves key generic versions of Zyprexa
Zyprexa posted sales of $5.7 billion endure time representing drugmaker Eli Lilly & Co Inc., according to prescription tracking company IMS physical condition.The latest low-cost versions of the drug hope against hope occur marketed by Indian generic drugmaker Dr. Reddys Laboratories and by Teva Pharmaceutical Industries, based modish Israel.Zyprexa is part of a panache of medications called atypical antipsychotics with the aim of effect levels of dopamine, a understanding substance with the aim of controls behavior, mood and movement.